Network pharmacology analysis and experimental validation of Yinma Jiedu Granule in the treatment of acute pharyngitis
Abstract
Yinma Jiedu Granules (YMJD) is a classical Chinese medicinal formula for alleviating inflammatory conditions, such as acute bronchitis and tracheitis. In this study, network pharmacology identified AKT1, IL6, and IL1B as hub genes, and molecular docking confirmed their binding to active ingredients (naringenin, quercetin, and aloe-emodin). Moreover, pathway enrichment analysis indicated YMJD alleviated acute pharyngitis by suppressing oxidative stress and PI3K-AKT signaling pathway. In acute pharyngitis rat model, YMJD improved the symptoms of acute pharyngitis. Mechanistic study showed that YMJD inhibited oxidative stress and inflammatory response through downregulation of PI3K/AKT/mTOR signaling pathway, providing evidence for YMJD to treat acute pharyngitis.
Read the paper
Related studies
- Quercetin Influences Quorum Sensing in Food Borne Bacteria: In-Vitro and In-Silico Evidence
- Phenolic-protein interactions: insight from in-silico analyses – a review
- In Silico Discovery of Candidate Drugs against Covid-19
- Neuropharmacological Effects of Quercetin: A Literature-Based Review
- In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting
- Effect of Quercetin Rich Onion Extracts on Bacterial Quorum Sensing
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.